Panel: Examining the Venture Capitalist Criteria for Intranasal Delivery Startup Investments
Time: 10:00 am
day: Day 1
Details:
- How venture capitalists assess the market size, unmet needs, and competitive dynamics of the intranasal delivery sector to gauge the potential for growth and return on investment
- Insights into the importance of demonstrating unique technology, strong intellectual property, and innovative approaches in drug formulation and delivery that set the startup apart from competitors
- Emphasis on the necessity of having a capable management team with relevant experience and a clear, executable business plan, including regulatory pathways and commercialization strategies, to instill investor confidence
